Log In
BCIQ
Print this Print this
 

TRK-380 (formerly TAC-301)

  Manage Alerts
Collapse Summary General Information
Company Toray Industries Inc.
DescriptionAdrenergic receptor beta 3 (ADRB3) agonist
Molecular Target Adrenergic receptor beta 3 (ADRB3)
Mechanism of ActionAdrenergic receptor beta 3 (ADRB3) agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationIncontinence
Indication DetailsTreat overactive bladder (OAB)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today